Chimeric Antigen Receptor T-Cell Therapy for Colorectal Cancer

Chimeric antigen receptor (CAR) T-cell therapy represents a new genetically engineered method of immunotherapy for cancer. The patient’s T-cells are modified to express a specific receptor that sticks to the tumor antigen. This modified cell is then reintroduced into the patient’s body to fight the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sur, Daniel, Havasi, Andrei, Cainap, Calin, Samasca, Gabriel, Burz, Claudia, Balacescu, Ovidiu, Lupan, Iulia, Deleanu, Diana, Irimie, Alexandru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019711/
https://www.ncbi.nlm.nih.gov/pubmed/31936611
http://dx.doi.org/10.3390/jcm9010182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019711/
https://www.ncbi.nlm.nih.gov/pubmed/31936611
http://dx.doi.org/10.3390/jcm9010182

Ejemplares similares